Hebao Yuan

3.9k total citations · 1 hit paper
40 papers, 2.9k citations indexed

About

Hebao Yuan is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Hebao Yuan has authored 40 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Cell Biology. Recurrent topics in Hebao Yuan's work include Ubiquitin and proteasome pathways (5 papers), Microtubule and mitosis dynamics (4 papers) and Peptidase Inhibition and Analysis (4 papers). Hebao Yuan is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Microtubule and mitosis dynamics (4 papers) and Peptidase Inhibition and Analysis (4 papers). Hebao Yuan collaborates with scholars based in United States, China and Germany. Hebao Yuan's co-authors include Duxin Sun, Xin Luan, Hongwei Chen, Kanokwan Sansanaphongpricha, Blanche Schwappach, Yukiko Yamashita, Danming Tang, Yanzhuang Wang, Mayu Inaba and Fei Liu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biomaterials.

In The Last Decade

Hebao Yuan

40 papers receiving 2.9k citations

Hit Papers

Engineering exosomes as r... 2017 2026 2020 2023 2017 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hebao Yuan United States 26 2.1k 616 438 345 311 40 2.9k
Xin A. Zhang United States 34 1.6k 0.7× 377 0.6× 695 1.6× 196 0.6× 413 1.3× 62 3.4k
Zbigniew Madeja Poland 28 1.4k 0.7× 344 0.6× 312 0.7× 436 1.3× 280 0.9× 136 2.7k
Melanie A. Simpson United States 36 3.1k 1.5× 428 0.7× 1.1k 2.5× 313 0.9× 451 1.5× 63 4.3k
Todd E. Fox United States 34 2.2k 1.0× 298 0.5× 518 1.2× 305 0.9× 260 0.8× 83 3.1k
Kun Guo China 33 1.7k 0.8× 795 1.3× 237 0.5× 173 0.5× 803 2.6× 122 3.3k
Matteo Parri Italy 29 1.7k 0.8× 724 1.2× 572 1.3× 215 0.6× 641 2.1× 59 3.0k
Lisa Oliver France 40 2.6k 1.3× 839 1.4× 386 0.9× 289 0.8× 838 2.7× 102 4.2k
Dan Lü United States 17 1.1k 0.5× 201 0.3× 473 1.1× 255 0.7× 277 0.9× 36 2.1k
Liang Liang China 30 1.5k 0.7× 686 1.1× 217 0.5× 205 0.6× 462 1.5× 100 2.8k
Zheng Cui China 24 1.7k 0.8× 352 0.6× 262 0.6× 234 0.7× 172 0.6× 67 2.8k

Countries citing papers authored by Hebao Yuan

Since Specialization
Citations

This map shows the geographic impact of Hebao Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hebao Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hebao Yuan more than expected).

Fields of papers citing papers by Hebao Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hebao Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hebao Yuan. The network helps show where Hebao Yuan may publish in the future.

Co-authorship network of co-authors of Hebao Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Hebao Yuan. A scholar is included among the top collaborators of Hebao Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hebao Yuan. Hebao Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Xinrui, Hua Jiang, Hebao Yuan, et al.. (2023). Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl)pyrrole-Based Stimulation-2 (ST2) Inhibitors. ACS Pharmacology & Translational Science. 6(9). 1275–1287. 2 indexed citations
2.
Zhang, Tao, Bruno Caetano Trindade, Kathryn A. Eaton, et al.. (2022). A steamed broccoli sprout diet preparation that reduces colitis via the gut microbiota. The Journal of Nutritional Biochemistry. 112. 109215–109215. 17 indexed citations
3.
Gao, Wei, Hongxiang Hu, Lipeng Dai, et al.. (2022). Structure‒tissue exposure/selectivity relationship (STR) correlates with clinical efficacy/safety. Acta Pharmaceutica Sinica B. 12(5). 2462–2478. 13 indexed citations
4.
Guo, Hongwei, Hebao Yuan, Xin Huang, et al.. (2021). Author Correction: Litchi seed extracts diminish prostate cancer progression via induction of apoptosis and attenuation of EMT through Akt/GSK-3β signaling. Scientific Reports. 11(1). 15201–15201. 1 indexed citations
5.
Luan, Xin, Hebao Yuan, Yudong Song, et al.. (2021). Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation. Biomaterials. 275. 120910–120910. 53 indexed citations
6.
Jin, Jinmei, Ye Wu, Yiwen Shen, et al.. (2020). The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination. Theranostics. 10(22). 10141–10153. 100 indexed citations
7.
Lan, Taijin, Qiaofeng Li, Ming Chang, et al.. (2020). Lei-gong-gen formula granule attenuates hyperlipidemia in rats via cGMP-PKG signaling pathway. Journal of Ethnopharmacology. 260. 112989–112989. 22 indexed citations
8.
Chang, Ming, Taijin Lan, Hebao Yuan, et al.. (2019). Mangiferin suppresses allergic asthma symptoms by decreased Th9 and Th17 responses and increased Treg response. Molecular Immunology. 114. 233–242. 27 indexed citations
9.
Li, Feng, Huixia Zhang, Miao He, et al.. (2018). Different Nanoformulations Alter the Tissue Distribution of Paclitaxel, Which Aligns with Reported Distinct Efficacy and Safety Profiles. Molecular Pharmaceutics. 15(10). 4505–4516. 19 indexed citations
10.
Guo, Hongwei, Hebao Yuan, Shu Pan, et al.. (2017). Litchi seed extracts diminish prostate cancer progression via induction of apoptosis and attenuation of EMT through Akt/GSK-3β signaling. Scientific Reports. 7(1). 41656–41656. 50 indexed citations
11.
Luan, Xin, et al.. (2017). Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacologica Sinica. 38(6). 754–763. 951 indexed citations breakdown →
12.
Sun, Lichao, Hebao Yuan, Joseph Burnett, et al.. (2016). CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer. Journal of Cancer. 7(10). 1197–1204. 31 indexed citations
13.
Tang, Danming, Xiaoyan Zhang, Shijiao Huang, et al.. (2015). Mena–GRASP65 interaction couples actin polymerization to Golgi ribbon linking. Molecular Biology of the Cell. 27(1). 137–152. 36 indexed citations
14.
Inaba, Mayu, Hebao Yuan, & Yukiko Yamashita. (2011). String (Cdc25) regulates stem cell maintenance, proliferation and aging in Drosophila testis. Development. 138(23). 5079–5086. 37 indexed citations
15.
Vielemeyer, Ole, Hebao Yuan, Sandrine Moutel, et al.. (2009). Direct Selection of Monoclonal Phosphospecific Antibodies without Prior Phosphoamino Acid Mapping. Journal of Biological Chemistry. 284(31). 20791–20795. 18 indexed citations
16.
Yamashita, Yukiko, Hebao Yuan, Jun Cheng, & Alan Hunt. (2009). Polarity in Stem Cell Division: Asymmetric Stem Cell Division in Tissue Homeostasis. Cold Spring Harbor Perspectives in Biology. 2(1). a001313–a001313. 88 indexed citations
17.
Váradi, Anikó, Tamara Nicolson, Marco Magistri, et al.. (2006). Intracellular ATP-sensitive K+ channels in mouse pancreatic beta cells: against a role in organelle cation homeostasis. Diabetologia. 49(7). 1567–1577. 35 indexed citations
18.
Yuan, Hebao, et al.. (2006). Scavenging of 14-3-3 proteins reveals their involvement in the cell-surface transport of ATP-sensitive K+ channels. Journal of Cell Science. 119(20). 4353–4363. 44 indexed citations
19.
Yuan, Hebao, et al.. (2003). 14-3-3 Dimers Probe the Assembly Status of Multimeric Membrane Proteins. Current Biology. 13(8). 638–646. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026